KCT0008226
Not yet recruiting
未知
A clinical study to evaluate the efficacy and safety of MegaCarti® as a treatment for cartilage regeneration in patients with knee joint cartilage injury : Multicenter, microfracture control, randomization, superiority clinical trial
&C BIO0 sites64 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Injury, poisoning and certain other consequences of external causes
- Sponsor
- &C BIO
- Enrollment
- 64
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All subjects can participate in the clinical trial only when all of the following criteria are met.
- •? 51 years to 65 years
- •? Subject or legal representatives who voluntarily decide to participate in the clinical trial and give written consent after hearing a detailed explanation of this clinical trial and fully understanding it
- •? Defect: International Cartilage Repair Society(ICRS) Grade III or IV single defect chondral lesion on knee cartilage
- •? Subject whose primary lesion site can be designated as one section of the knee joint, and the area can be determined as the main cause of clinical symptoms
- •? Knee cartilage defect size : below 10cm2
- •? Subject who need concurrent Misalignment correction osteotomy(Subject who perform high tibial osteotomy due to varus deformity above \-5 degrees in Hip\-knee\-ankle angle)
Exclusion Criteria
- •If any of the following items apply, the subject is excluded from the clinical trial.
- •?Subject who have autoimmune disease (Ex. Rheumatoid arthritis)
- •?When screening, Subject who have had trauma or cartilage damage or have undergone ligament surgery in the same knee as the surgical site within the past 1 year
- •?When screening, Subject who underwent surgery related to cartilage defect treatment, such as microfracture, autologous chondrocyte therapy in the same knee joint as the surgical site within the past year (Possible for arthroscopy for diagnostic purposes)
- •?When screening, Subject who received intra\-articular hyaluronic acid or steroid injection in the same knee as the surgical site within 2 months
- •?When screening, Subject who took oral steroids within 1 month
- •?Subject taking immunosuppressive drugs or immune disorder
- •?Subject with a history of cancer within the past 5 years
- •?BMI index : 35kg/m2 or more
- •?Subject with have gout or gout history in the same knee as the surgical site
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical study to evaluate the advanatges and safety of long term CurQfen consumption in dementia patientsHealth Condition 1: null- DementiaCTRI/2018/03/012410Akay Flavours and Aromatics Private Limited48
Not yet recruiting
Phase 2
A trial to check the effect of Capsule and syrup Shwasi in the management of Shwas Roga w.s.r. to Bronchial Asthma.Health Condition 1: null- Patients with Episodic Bronchial AsthmaCTRI/2018/01/011184Shree Dhanwantri Herbals Amritsar
Completed
Not Applicable
A clinical study to evaluate the efficacy and safety of docetaxel with ribavirin in patients with progressive prostate cancer who have previously recieved docetaxelJPRN-UMIN000012521Department of Urology, Keio University School of Medicine20
Completed
Phase 4
Evaluate the safety and efficacy of test product in improvement of skin .CTRI/2023/02/050063ZeusHygia Life sciences Pvt Ltd80
Recruiting
Phase 2
Clinical study to evaluate the Efficacy and safety of nutraceutical formulation in neurodegenerative diseases linked to cognitive impairmentHealth Condition 1: G300- Alzheimers disease with early onsetCTRI/2022/03/040964CSIR